Unacceptable Principal Diagnosis Codes
ICD-10-CM codes identified as unacceptable when used as principal diagnosis by MCE edit logic.
- R40.2443Billable
Other coma, without documented Glasgow coma scale score, or with partial score reported, at hospital admission
- R40.2444Billable
Other coma, without documented Glasgow coma scale score, or with partial score reported, 24 hours or more after hospital admission
- R40.2ABillable
Nontraumatic coma due to underlying condition
- R41.83Billable
Borderline intellectual functioning
- R45.850Billable
Homicidal ideations
- R46.81Billable
Obsessive-compulsive behavior
- R46.89Billable
Other symptoms and signs involving appearance and behavior
- R65.10Billable
Systemic inflammatory response syndrome (SIRS) of non-infectious origin without acute organ dysfunction
- R65.11Billable
Systemic inflammatory response syndrome (SIRS) of non-infectious origin with acute organ dysfunction
- R65.20Billable
Severe sepsis without septic shock
- R65.21Billable
Severe sepsis with septic shock
- S06.A0XABillable
Traumatic brain compression without herniation, initial encounter
- S06.A0XDBillable
Traumatic brain compression without herniation, subsequent encounter
- S06.A0XSBillable
Traumatic brain compression without herniation, sequela
- S06.A1XABillable
Traumatic brain compression with herniation, initial encounter
- S06.A1XDBillable
Traumatic brain compression with herniation, subsequent encounter
- S06.A1XSBillable
Traumatic brain compression with herniation, sequela
- T36.0X5ABillable
Adverse effect of penicillins, initial encounter
- T36.0X5DBillable
Adverse effect of penicillins, subsequent encounter
- T36.0X5SBillable
Adverse effect of penicillins, sequela
- T36.0X6ABillable
Underdosing of penicillins, initial encounter
- T36.0X6DBillable
Underdosing of penicillins, subsequent encounter
- T36.0X6SBillable
Underdosing of penicillins, sequela
- T36.1X5ABillable
Adverse effect of cephalosporins and other beta-lactam antibiotics, initial encounter
- T36.1X5DBillable
Adverse effect of cephalosporins and other beta-lactam antibiotics, subsequent encounter
- T36.1X5SBillable
Adverse effect of cephalosporins and other beta-lactam antibiotics, sequela
- T36.1X6ABillable
Underdosing of cephalosporins and other beta-lactam antibiotics, initial encounter
- T36.1X6DBillable
Underdosing of cephalosporins and other beta-lactam antibiotics, subsequent encounter
- T36.1X6SBillable
Underdosing of cephalosporins and other beta-lactam antibiotics, sequela
- T36.2X5ABillable
Adverse effect of chloramphenicol group, initial encounter
- T36.2X5DBillable
Adverse effect of chloramphenicol group, subsequent encounter
- T36.2X5SBillable
Adverse effect of chloramphenicol group, sequela
- T36.2X6ABillable
Underdosing of chloramphenicol group, initial encounter
- T36.2X6DBillable
Underdosing of chloramphenicol group, subsequent encounter
- T36.2X6SBillable
Underdosing of chloramphenicol group, sequela
- T36.3X5ABillable
Adverse effect of macrolides, initial encounter
- T36.3X5DBillable
Adverse effect of macrolides, subsequent encounter
- T36.3X5SBillable
Adverse effect of macrolides, sequela
- T36.3X6ABillable
Underdosing of macrolides, initial encounter
- T36.3X6DBillable
Underdosing of macrolides, subsequent encounter
- T36.3X6SBillable
Underdosing of macrolides, sequela
- T36.4X5ABillable
Adverse effect of tetracyclines, initial encounter
- T36.4X5DBillable
Adverse effect of tetracyclines, subsequent encounter
- T36.4X5SBillable
Adverse effect of tetracyclines, sequela
- T36.4X6ABillable
Underdosing of tetracyclines, initial encounter
- T36.4X6DBillable
Underdosing of tetracyclines, subsequent encounter
- T36.4X6SBillable
Underdosing of tetracyclines, sequela
- T36.5X5ABillable
Adverse effect of aminoglycosides, initial encounter
- T36.5X5DBillable
Adverse effect of aminoglycosides, subsequent encounter
- T36.5X5SBillable
Adverse effect of aminoglycosides, sequela
- T36.5X6ABillable
Underdosing of aminoglycosides, initial encounter
- T36.5X6DBillable
Underdosing of aminoglycosides, subsequent encounter
- T36.5X6SBillable
Underdosing of aminoglycosides, sequela
- T36.6X5ABillable
Adverse effect of rifampicins, initial encounter
- T36.6X5DBillable
Adverse effect of rifampicins, subsequent encounter
- T36.6X5SBillable
Adverse effect of rifampicins, sequela
- T36.6X6ABillable
Underdosing of rifampicins, initial encounter
- T36.6X6DBillable
Underdosing of rifampicins, subsequent encounter
- T36.6X6SBillable
Underdosing of rifampicins, sequela
- T36.7X5ABillable
Adverse effect of antifungal antibiotics, systemically used, initial encounter
- T36.7X5DBillable
Adverse effect of antifungal antibiotics, systemically used, subsequent encounter
- T36.7X5SBillable
Adverse effect of antifungal antibiotics, systemically used, sequela
- T36.7X6ABillable
Underdosing of antifungal antibiotics, systemically used, initial encounter
- T36.7X6DBillable
Underdosing of antifungal antibiotics, systemically used, subsequent encounter
- T36.7X6SBillable
Underdosing of antifungal antibiotics, systemically used, sequela
- T36.8X5ABillable
Adverse effect of other systemic antibiotics, initial encounter
- T36.8X5DBillable
Adverse effect of other systemic antibiotics, subsequent encounter
- T36.8X5SBillable
Adverse effect of other systemic antibiotics, sequela
- T36.8X6ABillable
Underdosing of other systemic antibiotics, initial encounter
- T36.8X6DBillable
Underdosing of other systemic antibiotics, subsequent encounter
- T36.8X6SBillable
Underdosing of other systemic antibiotics, sequela
- T36.95XABillable
Adverse effect of unspecified systemic antibiotic, initial encounter
- T36.95XDBillable
Adverse effect of unspecified systemic antibiotic, subsequent encounter
- T36.95XSBillable
Adverse effect of unspecified systemic antibiotic, sequela
- T36.96XABillable
Underdosing of unspecified systemic antibiotic, initial encounter
- T36.96XDBillable
Underdosing of unspecified systemic antibiotic, subsequent encounter
- T36.96XSBillable
Underdosing of unspecified systemic antibiotic, sequela
- T36.AX5ABillable
Adverse effect of fluoroquinolone antibiotics, initial encounter
- T36.AX5DBillable
Adverse effect of fluoroquinolone antibiotics, subsequent encounter
- T36.AX5SBillable
Adverse effect of fluoroquinolone antibiotics, sequela
- T36.AX6ABillable
Underdosing of fluoroquinolone antibiotics, initial encounter
- T36.AX6DBillable
Underdosing of fluoroquinolone antibiotics, subsequent encounter
- T36.AX6SBillable
Underdosing of fluoroquinolone antibiotics, sequela
- T37.0X5ABillable
Adverse effect of sulfonamides, initial encounter
- T37.0X5DBillable
Adverse effect of sulfonamides, subsequent encounter
- T37.0X5SBillable
Adverse effect of sulfonamides, sequela
- T37.0X6ABillable
Underdosing of sulfonamides, initial encounter
- T37.0X6DBillable
Underdosing of sulfonamides, subsequent encounter
- T37.0X6SBillable
Underdosing of sulfonamides, sequela
- T37.1X5ABillable
Adverse effect of antimycobacterial drugs, initial encounter
- T37.1X5DBillable
Adverse effect of antimycobacterial drugs, subsequent encounter
- T37.1X5SBillable
Adverse effect of antimycobacterial drugs, sequela
- T37.1X6ABillable
Underdosing of antimycobacterial drugs, initial encounter
- T37.1X6DBillable
Underdosing of antimycobacterial drugs, subsequent encounter
- T37.1X6SBillable
Underdosing of antimycobacterial drugs, sequela
- T37.2X5ABillable
Adverse effect of antimalarials and drugs acting on other blood protozoa, initial encounter
- T37.2X5DBillable
Adverse effect of antimalarials and drugs acting on other blood protozoa, subsequent encounter
- T37.2X5SBillable
Adverse effect of antimalarials and drugs acting on other blood protozoa, sequela
- T37.2X6ABillable
Underdosing of antimalarials and drugs acting on other blood protozoa, initial encounter
- T37.2X6DBillable
Underdosing of antimalarials and drugs acting on other blood protozoa, subsequent encounter
